Tolebrutinib reduces brain lesions in very active MS TrialPhase 2 ConferenceAAN 2021 16 June, 2021 11:50
Targeting cells in the CNS key to abrogate multiple sclerosis progression Presented ByProf. Tony Traboulsee , University of British Columbia, Vancouver, Canada ConferenceAAN 2021 29 April, 2021 13:22